Qiagen will provide IUO tests for NeoGenomics to verify, set up, and run in clinical trials and in anticipation of regulatory approval.

For the two five year grants, the NIH will favor applicants with experience providing counseling throughout the US and to diverse and disadvantaged communities.  

A GWAS meta-analysis involving hundreds of thousands of cases and controls led to new and known gallstone disease-associated variants at 28 loci.

Following a pilot project, Genome Biology is to adopt a transparent peer review process at the beginning of 2019.

Retraction Watch reports Ohio State has pushed Carlo Croce to step down as department chair.

DNA analysis may assist in the identification of victims of the Camp Fire in California, The Scientist reports.

In Science this week: single-cell analysis of colorectal cancers finds genome-wide demethylation patterns, and more.

Qiagen announced the European launch of its QiaScreen HPV PCR test, a CE-IVD marked molecular diagnostic assay for 15 recognized high-risk genotypes of human papillomavirus associated with cervical cancer. The assay is designed to detect a range of DNA targets within the E7 region of the HPV virus, providing the flexibility of PCR without the risk of false positives due to L1 deletion, Qiagen said. The clinical performance of the assay was tested using nearly 1,600 samples from the Valgent-3 panel, and was reported to have a clinical sensitivity and specificity to CIN3+ of 97.3 percent and 89.0 percent, respectively. The assay is designed for use on either clinician-collected or self-collected specimens, and it has been validated on Qiagen's Rotor-Gene Q MDx system. Qiagen also intends to offer a version of the test on the NeuMoDx 96 and 288 molecular systems in the future for customers desiring higher-volume testing and full integration.

Led by investigators at the University of Trento in Italy, the team received a five-year, £5 million ($6.4 million) award recently to advance its work.

The Australian researchers plan to use the technique in an exome sequencing study of 25,000 individuals with epilepsy and aim to develop it into a clinical test.

The new entity will offer comprehensive genomic services for precision medicine and drug discovery for central nervous system diseases.

The company is developing a single-molecule sequencing technology intended to significantly reduce the cost and improve the accuracy of sequencing.

DermTech has appointed Stevan Knezevich to its scientific advisory board. Knezevich has a PhD in pathology and laboratory medicine from the University of Vancouver, B.C., and a MD from the University of Toronto. 

Researchers from Peking University used their method, called scTrio-seq2, to characterize and trace genetic lineages of colorectal cancer cells.

The researchers reported that targeting HDAC4 in the patient-derived neurons appeared to correct the expression of genes that differed in the disease state.

Respondents to GenomeWeb's salary survey reported variations in their salaries that varied by sector.

Using peptide arrays, researchers identified a number of protein methylation sites and found that such sites are likely underrepresented in mass spec datasets.

With a DNA methylation atlas and deconvolution algorithm, researchers are attempting to trace cfDNA back to tissue sources in healthy or ill individuals.

Karius said it will use the money to continue commercialization of its diagnostic technologies and to fund clinical studies, among other things.

Even as He Jiankui expressed pride in the work he had done to alter the CCR5 genes of twin embryos, researchers and ethicists decried him as misguided.

The UK developers believe that their device has the potential for multiplex testing at the point of care using solid-state nanopore sensing with DNA probes.

The New York Times reports China has suspended the work of He Jiankui, who announced this week the birth of two gene-edited babies.